Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6300
-0.0300 (-1.81%)
NASDAQ· Last Trade: Jun 7th, 9:42 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors